Literature DB >> 15465502

RETRACTED: Comparative efficacy of hormone replacement therapy, etidronate, calcitonin, alfacalcidol, and vitamin K in postmenopausal women with osteoporosis: The Yamaguchi Osteoporosis Prevention Study.

Yoichiro Ishida1, Shinya Kawai.   

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Editor in Chief because of the stated concerns listed below. This article was accepted for publication by a previous editor and editorial board, at a time when submissions and documentation were in paper form, prior to the transition of The American Journal of Medicine to a digital submission and review process. These records are no longer extant and consequently we are unable to review the comments of the reviewers and editors involved at that time. We have attempted to contact the authors regarding these concerns and received no response. We are therefore retracting this article since the evidence presented below strongly argues for scientific misconduct. The integrity of these publications is severely compromised by wide-ranging and serious concerns about governance, ethics, authorship, implausible study conduct, implausible workload, discrepant participant numbers and treatment groups, impossible data, implausible data, implausible outcome data, and discrepant methodology.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15465502     DOI: 10.1016/j.amjmed.2004.05.019

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  31 in total

Review 1.  Efficacy of antiresorptive agents for preventing fractures in Japanese patients with an increased fracture risk: review of the literature.

Authors:  Jun Iwamoto; Yoshihiro Sato; Tsuyoshi Takeda; Hideo Matsumoto
Journal:  Drugs Aging       Date:  2012-03-01       Impact factor: 3.923

2.  Calcium and vitamin D in preventing fractures: vitamin K supplementation has powerful effect.

Authors:  Thomas E Radecki
Journal:  BMJ       Date:  2005-07-09

3.  Possible site-specific effect of an intervention combining nutrition and lifestyle counselling with consumption of fortified dairy products on bone mass: the Postmenopausal Health Study II.

Authors:  George Moschonis; Spyridon Kanellakis; Nikolaos Papaioannou; Anne Schaafsma; Yannis Manios
Journal:  J Bone Miner Metab       Date:  2011-04-01       Impact factor: 2.626

4.  Additive effect of elcatonin to risedronate for chronic back pain and quality of life in postmenopausal women with osteoporosis: a randomized controlled trial.

Authors:  Michio Hongo; Naohisa Miyakoshi; Yuji Kasukawa; Yoshinori Ishikawa; Yoichi Shimada
Journal:  J Bone Miner Metab       Date:  2014-08-15       Impact factor: 2.626

5.  Effect of GGCX gene polymorphism on the responses of serum undercarboxylated osteocalcin and bone turnover markers after treatment with vitamin K2 (menatetrenone) among postmenopausal Thai women.

Authors:  Thawee Songpatanasilp; La-or Chailurkit; Suwannee Chantprasertyothin; Boonsong Ongphiphadhanakul; Nimit Taechakraichana
Journal:  J Bone Miner Metab       Date:  2011-02-23       Impact factor: 2.626

6.  Short-term menatetrenone therapy increases gamma-carboxylation of osteocalcin with a moderate increase of bone turnover in postmenopausal osteoporosis: a randomized prospective study.

Authors:  Masataka Shiraki; Akira Itabashi
Journal:  J Bone Miner Metab       Date:  2009-01-27       Impact factor: 2.626

7.  Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2006-11-01

8.  Vitamin K2 supplementation does not influence bone loss in early menopausal women: a randomised double-blind placebo-controlled trial.

Authors:  N Emaus; C G Gjesdal; B Almås; M Christensen; A S Grimsgaard; G K R Berntsen; L Salomonsen; V Fønnebø
Journal:  Osteoporos Int       Date:  2009-11-25       Impact factor: 4.507

Review 9.  Efficacy of menatetrenone (vitamin K2) against non-vertebral and hip fractures in patients with neurological diseases: meta-analysis of three randomized, controlled trials.

Authors:  Jun Iwamoto; Hideo Matsumoto; Tsuyoshi Takeda
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

10.  Low-dose vitamin K2 (MK-4) supplementation for 12 months improves bone metabolism and prevents forearm bone loss in postmenopausal Japanese women.

Authors:  Noriko Koitaya; Mariko Sekiguchi; Yuko Tousen; Yoriko Nishide; Akemi Morita; Jun Yamauchi; Yuko Gando; Motohiko Miyachi; Mami Aoki; Miho Komatsu; Fumiko Watanabe; Koji Morishita; Yoshiko Ishimi
Journal:  J Bone Miner Metab       Date:  2013-05-24       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.